CTLA4 and activated PI3K-delta syndrome: There have been multiple retrospective studies showing an improvement in disease manifestations, e.g., in APDS [145, 146], CTLA-4 haploinsufficient [137], LRBA deficient [70], and STAT3 GOF [84, 143] patients.